arrow
J

Jinkwon Kim

yongin severance hospital
H指数:37
被引数:4,379

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of cytochrome P450 2C19 genotypes with effectiveness of clopidogrel in ischemic stroke by smoking status

吸烟状况下细胞色素P450 2C19基因型与氯吡格雷在缺血性脑卒中中的疗效关联

2026-07-020
OA
Clinical Application of Pharmacogenomics in Stroke Management: Current Evidence and Future Directions

药物基因组学在卒中管理中的临床应用:当前证据和未来方向

2026-01-010
OAAI
Comparison of clopidogrel-based antiplatelet therapy versus warfarin as secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trial

比较氯吡格雷为基础的抗血小板治疗与华法林作为抗磷脂综合征相关卒中(APS-STROKE)二级预防策略的对照研究:一项前瞻性、随机、开放标签、盲终点试验的方案与设计

2025-12-010
PRE
Thrombus composition and distribution patterns by thrombus volume in acute ischemic stroke

急性缺血性卒中中血栓的组成和分布模式按血栓体积划分

2025-08-170
OA
Blood pressure threshold and outcomes after successful endovascular thrombectomy

血压阈值及成功经导管取栓后的结局

2025-08-010
PRE
Blood pressure management based on infarct volume after successful endovascular thrombectomy

基于梗死体积的血压管理策略在成功进行血管内血栓切除术后

2025-05-020
PRE
Effects of blood pressure lowering in patients treated with intravenous thrombolysis before endovascular thrombectomy
2025-02-060
PRE
Nelonemdaz and Patients With Acute Ischemic Stroke and Mechanical Reperfusion: The RODIN Randomized Clinical Trial

Nelonemdaz 和急性缺血性卒中及机械再灌注患者:RODIN 随机临床试验

2025-01-280
OA
Intensive blood pressure lowering in acute stroke with intracranial stenosis post-thrombectomy: A secondary analysis of the OPTIMAL-BP trial
2025-01-020
PRE